Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
TNF Pharmaceuticals, Inc. See All Filings	D	2025-09-05 17:30:17 UTC
Amount To Be Raised $7,000,000 Associated Brokers / Dealers GP Nurmenkari Inc., Rodman & Renshaw, LLC, and H.C. Wainwright & Co., LLC CIK Number 0001321834 Filed Document 0001641172-25-026761 Exclusions or Exemptions 506b Accepted Date 2025-09-05 17:30:17 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business NEW YORK Revenue or Assets Decline to Disclose Type of Security Equity
MyMD Pharmaceuticals, Inc. See All Filings	D	2024-05-31 08:00:27 UTC
Amount To Be Raised $15,150,007 Associated Brokers / Dealers Palladium Capital Group, LLC and GP Nurmenkari Inc. CIK Number 0001321834 Filed Document 0001493152-24-022083 Exclusions or Exemptions 506b Accepted Date 2024-05-31 08:00:27 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business MARYLAND Revenue or Assets Decline to Disclose Type of Security Equity
MyMD Pharmaceuticals, Inc. See All Filings	D	2024-05-31 08:00:25 UTC
Amount To Be Raised $26,850,006 Associated Brokers / Dealers Palladium Capital Group, LLC and GP Nurmenkari Inc. CIK Number 0001321834 Filed Document 0001493152-24-022082 Exclusions or Exemptions 506b Accepted Date 2024-05-31 08:00:25 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business MARYLAND Revenue or Assets Decline to Disclose Type of Security Equity
MyMD Pharmaceuticals, Inc. See All Filings	D	2022-08-30 08:00:23 UTC
Amount To Be Raised $7,411,761 Associated Brokers / Dealers Dawson James Securities, Inc. CIK Number 0001321834 Filed Document 0001493152-22-024345 Exclusions or Exemptions 506b Accepted Date 2022-08-30 08:00:23 UTC Type of Offering D Industry Other Health Care Principal Place of Business MARYLAND Revenue or Assets Decline to Disclose Type of Security Option To Acquire
Akers Biosciences, Inc. See All Filings	D	2020-11-24 16:21:05 UTC
Amount To Be Raised $18,067,000 Associated Brokers / Dealers Katalyst Securities LLC CIK Number 0001321834 Filed Document 0001493152-20-022415 Exclusions or Exemptions 506b Accepted Date 2020-11-24 16:21:05 UTC Type of Offering D Industry Other Health Care Principal Place of Business NEW JERSEY Revenue or Assets Decline to Disclose Type of Security Equity
Akers Biosciences, Inc. See All Filings	D	2020-08-11 15:49:18 UTC
Amount To Be Raised $0 Associated Brokers / Dealers N/A CIK Number 0001321834 Filed Document 0001493152-20-015232 Exclusions or Exemptions 506b Accepted Date 2020-08-11 15:49:18 UTC Type of Offering D Industry Other Health Care Principal Place of Business NEW JERSEY Revenue or Assets Decline to Disclose Type of Security Equity
Akers Biosciences, Inc. See All Filings	D	2020-05-21 15:01:49 UTC
Amount To Be Raised $482,498 Associated Brokers / Dealers N/A CIK Number 0001321834 Filed Document 0001493152-20-009612 Exclusions or Exemptions 506b Accepted Date 2020-05-21 15:01:49 UTC Type of Offering D Industry Other Health Care Principal Place of Business NEW JERSEY Revenue or Assets Decline to Disclose Type of Security Option To Acquire
Akers Biosciences, Inc. See All Filings	D	2020-04-14 14:28:32 UTC
Amount To Be Raised $459,998 Associated Brokers / Dealers N/A CIK Number 0001321834 Filed Document 0001493152-20-006344 Exclusions or Exemptions 506b Accepted Date 2020-04-14 14:28:32 UTC Type of Offering D Industry Other Health Care Principal Place of Business NEW JERSEY Revenue or Assets Decline to Disclose Type of Security Option To Acquire
Akers Biosciences, Inc. See All Filings	D	2020-04-07 17:11:13 UTC
Amount To Be Raised $2,718,057 Associated Brokers / Dealers N/A CIK Number 0001321834 Filed Document 0001493152-20-006006 Exclusions or Exemptions 506b Accepted Date 2020-04-07 17:11:13 UTC Type of Offering D Industry Other Health Care Principal Place of Business NEW JERSEY Revenue or Assets Decline to Disclose Type of Security Equity
Akers Biosciences, Inc. See All Filings	D	2017-04-13 16:13:00 UTC
Amount To Be Raised $2,027,760 Associated Brokers / Dealers None CIK Number 0001321834 Filed Document 0001493152-17-003835 Exclusions or Exemptions 506b Accepted Date 2017-04-13 16:13:00 UTC Type of Offering D Industry Other Health Care Principal Place of Business NEW JERSEY Revenue or Assets Decline to Disclose Type of Security Equity